The researchers gathered deidentified data from 68 oncology EHRs, including four of the seven most frequently implemented to calculate interoperability scores.
To provide accurate analysis, the researchers used six medications and six laboratory tests, as they stated that data elements are received by EHRs differently. Even if EHRs are able to communicate across hospitals, the data may be unreadable when it gets to the receiving hospital.
They found that interoperability between hospitals using different vendors was lower than interoperability between hospitals using the same vendor, but even having the same vendor does not guarantee interoperability because the same EHR product may be implemented differently at different sites.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
